Cholestyramine and Multiple sclerosis aggravated - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis aggravated is reported as a side effect among people who take Cholestyramine (cholestyramine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Avonex, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Multiple sclerosis aggravated when taking Cholestyramine. It is created by eHealthMe based on reports of 9,676 people who have side effects when taking Cholestyramine from the FDA, and is updated regularly.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

What is Multiple sclerosis aggravated?

Multiple sclerosis aggravated (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,024 drugs and 323 conditions by eHealthMe. Check the latest studies of Multiple sclerosis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

9,676 people reported to have side effects when taking Cholestyramine.
Among them, 34 people (0.35%) have Multiple sclerosis aggravated.

Could Cholestyramine cause Multiple sclerosis aggravated?

Among these 34 people:

How long have people been on Cholestyramine when they have Multiple sclerosis aggravated? *

What is the gender of people who have Multiple sclerosis aggravated when taking Cholestyramine? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Multiple sclerosis aggravated when taking Cholestyramine? *

What are other drugs people take besides Cholestyramine? *

What are other side effects people have besides Multiple sclerosis aggravated? *

Urinary Tract Infection: 11 people, 32.35%
Memory Loss: 8 people, 23.53%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 23.53%
Confusional State: 8 people, 23.53%
Anticonvulsant Drug Level Decreased: 7 people, 20.59%
Fainting (loss of consciousness and postural tone): 7 people, 20.59%
Cataract (clouding of the lens inside the eye): 7 people, 20.59%
Glaucoma (increased fluid pressure in the eye with vision loss): 7 people, 20.59%
Back Pain: 6 people, 17.65%
Blindness: 6 people, 17.65%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 8.82%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 5.88%
Pain: 2 people, 5.88%
Muscle Spasms (muscle contraction): 2 people, 5.88%
Insomnia (sleeplessness): 2 people, 5.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.88%
Weakness: 1 person, 2.94%
Sleep Disorder: 1 person, 2.94%
Skin Wrinkling (wrinkle on skin): 1 person, 2.94%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Cholestyramine and have Multiple sclerosis aggravated?

- Check whether Multiple sclerosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cholestyramine:

Cholestyramine (9,893 reports)

Browse all side effects of Cholestyramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (1,024 drugs)

Browse all the conditions that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (323 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cholestyramine (the active ingredients of Cholestyramine) and Cholestyramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.